UCI concerned new drug "ten times more powerful than tramadol" could be
used by professional cyclists to mask fatigue during races, report suggests

The governing body has reportedly already told representatives of pro
cycling teams of its "concerns about a new substance", the "very powerful" painkiller usually prescribed in cases of severe osteoarthritis and bone cancer...
by DAN ALEXANDER
WED, JUN 12, 2024 10:45

The UCI is reportedly worried about the possibility of a powerful new painkiller making its way into pro races, with riders and teams having been warned of the governing body's "concerns" about the drug "ten times more powerful than tramadol".

Le Temps (link is external) broke the story yesterday evening, reporting
that tapentadol — a "very powerful" painkiller used to treat extreme pain, often in cases of severe osteoarthritis or bone cancer — could be one of
the UCI's current main doping concerns.

The Swiss newspaper reports the UCI's concerns about its potential use in
races has been simmering for the past few months, the governing body
obtaining permission from the World-Anti Doping Agency (WADA) to place it
on its monitoring programme at the end of 2023, ahead of a possible future
ban.

However, taking proactive action at a meeting last month, it is believed
the UCI has alerted representatives of riders, teams and organisers of the situation, Le Temps reporting that: "The UCI expresses its concerns about a
new substance which could be used to replace tramadol, called tapentadol. Further analysis needs to be carried out but, if [this substance] is used,
it is presented as being ten times more powerful than tramadol."

The Movement for Credible Cycling has urged the authorities to introduce a
ban on the substance, the very powerful painkilling abilities making it a potentially attractive shortcut for any riders inclined to use drugs to
mask fatigue during races.

It is feared, on top of the moral question about improving performance
through these means, that tapentadol may cause "very common" side effects
such as a reduction in alertness, as well as dizziness and drowsiness,
raising concerns about crashes. It was introduced by German pharmaceutical giant Grünenthal in 2011 and is generally used in a medical context in
cases involving extreme and severe pain, such as for patients of serious osteoarthritis, diabetes or bone cancer.

How much stronger than tramadol the painkiller is remains up for debate,
the UCI landing on a figure of "ten times more" powerful, however a 2012
study published in Expert Opinion on Pharmacotherapy suggested it may be
"two to five times more powerful" than tramadol.

"Athletes in good health do not need to use therapeutic products of this nature," Roger Legeay, the MPCC's president, told the Swiss news website.
"In addition, it should be noted that an analgesic reduces or eliminates
pain, which is a factor in improving performance. It took us twelve years
to obtain a ban on tramadol. This time, we hope that the proceedings will
be faster."

Tramadol was banned in 2019 and in the immediate aftermath of that
announcement the UCI carried out 143 tests on 117 riders at 11 WorldTour events, all coming back negative.

Nairo Quintana was disqualified from the 2022 Tour de France, losing his
sixth place finish, after analyses of two dried blood samples provided by
the rider on two dates during the race revealed the presence of tramadol
and its two main metabolites.

As infringements of the in-competition ban on using tramadol were offences under the UCI Medical Rules, and it was Quintana's first offence, he was
not banned from competition and raced at the World Championships that
autumn.

In 2017, retired professional cyclist Michael Barry claimed Team Sky were
"not ethical" in terms of administering medication to riders when he was
with them. Barry, who admitted doping during his own professional career
with the United States Postal Service (USPS) team, said he had concerns
about tramadol use.

<https://road.cc/content/news/uci-concerned-powerful-new-drug-308823>


--
Spike

--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)